The Healthy Human Global Project - Hong Kong (HHGP-Hong Kong)
NCT05174624 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1026
Last updated 2023-10-04
Summary
The Healthy Human Global Project-Hong Kong aims to elucidate the heritable and non-heritable factors that drive immunological variance within a healthy population in Hong Kong. By gaining a deeper understanding of these parameters, a path can be paved for personalised and precision medicine, tailored for an Asian population.
Conditions
- Healthy
- Immune System and Related Disorders
Interventions
- OTHER
-
No intervention
No intervention
Sponsors & Collaborators
-
The University of Hong Kong
collaborator OTHER -
Institut Pasteur
collaborator INDUSTRY -
Centre for Immunology & Infection
lead OTHER
Principal Investigators
-
James Di Santo · Centre for Immunology & Infection
-
Darragh Duffy · Centre for Immunology & Infection
-
Michael Ni · The University of Hong Kong
Eligibility
- Min Age
- 20 Years
- Max Age
- 79 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2022-07-01
- Primary Completion
- 2023-09-14
- Completion
- 2023-09-14
Countries
- China
Study Locations
More Related Trials
-
A Phase I/II Study of Universal Off-the-shelf NKG2D-ACE2 CAR-NK Cells for Therapy of COVID-19
NCT04324996 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
An Open Label Study of IgG Fc Glycan Composition in Human Immunity
NCT01967238 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
CX3CR1+T Cell Predict Immunotherapy Efficacy
NCT06054152 ·Status: COMPLETED
-
COVID-2019 Vaccine Immune Response Base on Single Cell Multi-Omics
NCT04871932 ·Status: RECRUITING
-
Safety and Efficiency of γδ T Cell Against Non Small Lung Cancer ( Without EGFR Mutation)
NCT02425748 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Immune Resistance Interrogation Study
NCT04243720 ·Status: RECRUITING
-
The Molecular Mechanism of CMV-driven NKG2C+NK Cell Expansion in Human
NCT04298502 ·Status: UNKNOWN
-
Sample Collection for Systems Evaluation of Patients With Unknown or Incompletely Characterized Immune Defects
NCT04408950 ·Status: COMPLETED
-
Clonal Fetal Mesenchymal Stem Cells (cfMSCs) for the Control of Immune-related Disorders
NCT03123458 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE1
-
The COX-2 Gene and the Immune System
NCT01678222 ·Status: COMPLETED
-
Studies of the Immune Response in Normal Subjects and Patients With Disorders of the Immune System
NCT00001158 ·Status: COMPLETED
-
An Experimental Medicine Clinical Study to Compare Peripheral Immune System From Subjects Without Cancer Diagnosis and Patients With Solid Tumours.
NCT05133128 ·Status: TERMINATED ·Phase: NA
-
TCR-T Cell Immunotherapy of Lung Cancer and Other Solid Tumors
NCT03778814 ·Status: RECRUITING ·Phase: PHASE1
-
Universal Dual-target NKG2D-NKp44 CAR-T Cells in Advanced Solid Tumors
NCT05976906 ·Status: UNKNOWN ·Phase: PHASE1
-
A Prospective Study to Observe Adverse Effects in Patients Receiving Anti-PD1 Immunotherapy
NCT05669638 ·Status: RECRUITING
-
Neoantigen-expanded Autologous Immune Cell Therapy
NCT05020119 ·Status: UNKNOWN ·Phase: PHASE1
-
Immunotherapy Based on Tumor Associated Antigen-specific Immune Effector Cells
NCT03535246 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies
NCT05995821 ·Status: RECRUITING
-
Allogeneic γδ T Cell Therapy for the Treatment of Solid Tumors
NCT04765462 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
This Study is Assessing the Safety and Efficacy of Immune Inhibition as a Treatment to Prevent Primary Graft Dysfunction
NCT06853223 ·Status: RECRUITING ·Phase: PHASE2
-
Phase I Study of OriC902 in Treatment of Advanced HCC
NCT06891742 ·Status: RECRUITING ·Phase: PHASE1
-
Collection of Data and Samples From Healthy Donors for Use in Translational Research
NCT00090662 ·Status: RECRUITING
-
The Clinical Significance of Peripheral Blood T Lymphocyte PD-1 Expression and T Cell Subset Distribution.
NCT06029829 ·Status: UNKNOWN ·Phase: PHASE2
-
Evaluation of Immune Signaling Networks in Healthy Human Volunteers
NCT01882582 ·Status: COMPLETED
-
Immunity to Infection in Healthy Participants and Participants With Cancer
NCT05787964 ·Status: ACTIVE_NOT_RECRUITING